VerburgFA, LusterM, CupiniC, ChiovatoL, DuntasL, EliseiR, Feldt-RasmussenU, RimmeleH, SeregniE, SmitJW, TheimerC, GiovanellaL. 2013. Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement. Thyroid, 23:1211–1225.
2.
SpencerC, FatemiS. 2013. Thyroglobulin antibody (TgAb) methods—strengths, pitfalls, clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer. Best Pract Res Clin Endocrinol Metab, 2013Aug12[Epub ahead of print];10.1016/j.beem.2013.07.003.
3.
SpencerC, PetrovicI, FatemiS. 2011. Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab, 96:1283–1291.
4.
LatrofaF, RicciD, MontanelliL, RocchiR, PiaggiP, SistiE, GrassoL, BasoloF, UgoliniC, PincheraA, VittiP. 2012. Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. J Clin Endocrinol Metab, 97:3974–3982.
5.
SpencerCA. 2011. Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC)J Clin Endocrinol Metab, 96:3615–3627.
6.
BalochZ, CarayonP, Conte-DevolxB, DemersLM, Feldt-RasmussenU, HenryJF, LiVosliVA, Niccoli-SireP, JohnR, RufJ, SmythPP, SpencerCA, StockigtJR. 2003. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid, 13:1–126.
7.
HoofnagleAN, RothMY. 2013. Improving the measurement of serum thyroglobulin with mass spectrometry. J Clin Endocrinol Metab, 98:1343–1352.
